Autres langues Oramed Pharmaceuticals Inc.

Actions

ORMP

US68403P2039

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
2,46 ^USD	+6,96 %		+8,37 %	+6,49 %

19/03	Oramed Pharmaceuticals Inc. nomme Yehuda Reznick au poste d'administrateur, à compter du 1er avril 2024	CI
06/03	Oramed Pharmaceuticals Inc. publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Oramed Pharmaceuticals : 13D-Nadav Kidron	26/03
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	19/03
Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	19/03
Oramed Pharmaceuticals : Other Report or Announcement	18/03
Oramed Pharmaceuticals : Other Report or Announcement	18/03
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors	19/01
Oramed Pharmaceuticals : Other Report or Announcement	02/01
Oramed Pharmaceuticals : Other Report or Announcement	24/12
Oramed Pharmaceuticals Inc. Appoints Daniel Aghion as Director, Effective January 1, 2024	19/12
Oramed Pharmaceuticals : Form 8-K - Director Appointment- Dr. Daniel Aghion, effective as of January 1, 2024.	19/12
Oramed: Q3 Earnings Snapshot	10/11
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Oramed Pharmaceuticals Inc.(TASE:ORMP) dropped from TA-125 Index	03/11
Scilex Consummates Purchase of Securities Owned by Sorrento Therapeutics	21/09/23
Scilex Holding Company announced that it has received $101.875 million in funding from Oramed Pharmaceuticals Inc.	21/09/23
Oramed Pharmaceuticals Inc. cancelled the acquisition of 40.17% stake in Scilex Holding Company from Sorrento Therapeutics, Inc. (OTCPK:SRNE.Q).	21/09/23
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Oramed Pharmaceuticals : Other Report or Announcement	07/08/23
Oramed Pharmaceuticals : Stalking Horse Stock Purchase Term Sheet - Form 8-K	07/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Oramed Pharmaceuticals Inc.

Actions

ORMP

US68403P2039

Autres langues

Filtres